Live site data
德琪医药
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for the treatment of hematologic malignancies and solid tumors, in realizing its vision of Treating Patients Beyond Borders.
Last refresh
Updated 18d ago
Analyst read
In review
53/100 trustStale snapshot
Detected stack
Vue.jsjQuery